Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Chris Lange | Mar 20, 2020 at 9:00 AM EDT

Meet the Newest and Maybe Quickest Coronavirus Test

GenMark Diagnostics stock shot up on Friday after the company announced that the FDA has issued an Emergency Use Authorization…

Paul Ausick | Mar 19, 2020 at 1:06 PM EDT

COVID-19 Patients Should Avoid Marijuana Products

People who have tested positive for coronavirus should avoid using cannabis products according to research firm Aurelius Data.

Chris Lange | Mar 18, 2020 at 11:33 AM EDT

Is Amarin Stock Poised for a Strong Recovery?

Amarin has been right in the middle of this recent market sell-off, and while shares have been halved, the stock…

Chris Lange | Mar 18, 2020 at 10:45 AM EDT

These Are the Top Coronavirus Cure and Vaccine Companies Trying to Save Us

24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel…

Chris Lange | Mar 18, 2020 at 9:45 AM EDT

BioNTech’s Coronavirus Vaccine Just Got Strong Backing

BioNTech stock jumped on Tuesday and went even higher early on Wednesday. This comes after the company announced a collaboration…

Paul Ausick | Mar 17, 2020 at 8:56 AM EDT

COVID-19 in the US: How Americans Are Reacting

A recent survey of U.S. adults shows rising concern over the spread of COVID-19 in the United States. Those worries…

Paul Ausick | Mar 16, 2020 at 1:13 PM EDT

Why Coronavirus Test Competition Shocked Aytu Bioscience Stock

Aytu Bioscience stock has had investors on a roller-coaster over the past week. The commercial-stage specialty pharmaceutical company has a…

Jon C. Ogg | Mar 13, 2020 at 1:17 PM EDT

Tilray’s Ghastly Timing for a Capital Raise

Tilray chose perhaps the worst time that it could to raise capital, as the prior trading day was the worst…

Paul Ausick | Mar 12, 2020 at 8:10 AM EDT

Are Limited Financing Options Punishing Bio-Path Stock?

Like all developmental drug companies, Bio-Path is betting on the success of its drug candidates. Drugs that are in trials…

Jon C. Ogg | Mar 11, 2020 at 1:40 PM EDT

As WHO Declares COVID-19 a Pandemic, What Really Changes?

he World Health Organization now has upgraded the COVID-19 outbreak to pandemic status, as the cases outside of China have…

Chris Lange | Mar 11, 2020 at 9:44 AM EDT

Short Sellers Run for Cover From Big Pharma Stocks

The February 28 short interest data have been compared with the previous figures, and short interest in these top pharmaceutical…

Chris Lange | Mar 11, 2020 at 9:13 AM EDT

Big Biotechs Have Short Sellers Confused

The February 28 short interest data has been compared with the previous report, and short interest moves in these selected…

Jon C. Ogg | Mar 10, 2020 at 2:18 PM EDT

The Coronavirus Diagnostics Trade Gets a New Stock Favorite

It is not a new scenario where an illness or problem starts to become a big deal in the public…

Chris Lange | Mar 10, 2020 at 11:10 AM EDT

Coronavirus Stocks Seeing the Biggest Bounce Back

More and more companies are joining the fight against the coronavirus, and 24/7 Wall St. is taking a look at…

Chris Lange | Mar 9, 2020 at 9:52 AM EDT

How Kala Pharma Is Surviving Monday’s Market Carnage

Kala Pharmaceuticals said that it had positive topline results from its late-stage clinical trial for the treatment of dry eye…

1 … 66 67 68 69 70 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Meet the Newest and Maybe Quickest Coronavirus Test

COVID-19 Patients Should Avoid Marijuana Products

Is Amarin Stock Poised for a Strong Recovery?

These Are the Top Coronavirus Cure and Vaccine Companies Trying to Save Us

BioNTech’s Coronavirus Vaccine Just Got Strong Backing

COVID-19 in the US: How Americans Are Reacting

Why Coronavirus Test Competition Shocked Aytu Bioscience Stock

Tilray’s Ghastly Timing for a Capital Raise

Are Limited Financing Options Punishing Bio-Path Stock?

As WHO Declares COVID-19 a Pandemic, What Really Changes?

Short Sellers Run for Cover From Big Pharma Stocks

Big Biotechs Have Short Sellers Confused

The Coronavirus Diagnostics Trade Gets a New Stock Favorite

Coronavirus Stocks Seeing the Biggest Bounce Back

How Kala Pharma Is Surviving Monday’s Market Carnage

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal

$400,000 in Employer Stock Inside Your 401(k)? This Tax Rule Could Save You $65,000 Before You Retire

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal

Health and Healthcare Articles

All Health and Healthcare Articles

Meet the Newest and Maybe Quickest Coronavirus Test

COVID-19 Patients Should Avoid Marijuana Products

Is Amarin Stock Poised for a Strong Recovery?

These Are the Top Coronavirus Cure and Vaccine Companies Trying to Save Us

BioNTech’s Coronavirus Vaccine Just Got Strong Backing

COVID-19 in the US: How Americans Are Reacting

Why Coronavirus Test Competition Shocked Aytu Bioscience Stock

Tilray’s Ghastly Timing for a Capital Raise

Are Limited Financing Options Punishing Bio-Path Stock?

As WHO Declares COVID-19 a Pandemic, What Really Changes?

Short Sellers Run for Cover From Big Pharma Stocks

Big Biotechs Have Short Sellers Confused

The Coronavirus Diagnostics Trade Gets a New Stock Favorite

Coronavirus Stocks Seeing the Biggest Bounce Back

How Kala Pharma Is Surviving Monday’s Market Carnage

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal

$400,000 in Employer Stock Inside Your 401(k)? This Tax Rule Could Save You $65,000 Before You Retire

Featured Reads

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal